Artiva Biotherapeutics, Inc. ARTV Unrealized Gains on Investments
Unrealized Gains on Investments at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s unrealized gains on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s unrealized gains on investments?
- Artiva Biotherapeutics, Inc. (ARTV) reported unrealized gains on investments of $26K in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s unrealized gains on investments changed year-over-year?
- Artiva Biotherapeutics, Inc.'s unrealized gains on investments decreased by 58.1% year-over-year, from $62K to $26K.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s unrealized gains on investments?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s unrealized gains on investments has grown at a -40.8% compound annual growth rate (CAGR), from $308K to $108K.